483 Document: KATALYST, Inc., Mar 28, 2019

FDANews 483 KATALYST, Inc. Mar 28 2019 top
Christopher S. Genther FDA Investigator

On Mar 28, 2019, the FDA inspected KATALYST, Inc.'s Seattle site. Explore the inspectional observations.